TY  - JOUR 
AU  - Lauper, K.
AU  - Mongin, D.
AU  - Alpizar-Rodriguez, D.
AU  - Codreanu, C.
AU  - Iannone, F.
AU  - Kristianslund, E. K.
AU  - Kvien, T. K.
AU  - Pavelka, K.
AU  - Pombo Suárez, Manuel
AU  - Santos, M. J.
AU  - Gabay, C.
AU  - Finckh, A.
AU  - Courvoisier, D. S.
PY  - 2019
SN  - 1462-0324
UR  - http://hdl.handle.net/20.500.11940/15488
AB  - OBJECTIVE: To examine the association of the evolution in physician-reported and patient-reported outcomes with decision to stop biological DMARDs (bDMARDs) in RA. The contribution of baseline characteristics is well established, but little is known...
TI  - Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution
DO  - 10.1093/rheumatology/kez221
T2  - RHEUMATOLOGY
M2  - 2221
KW  - CHUS
VL  - 58
ER  -